ExoDx Prostate Evaluation in Active Surveillance Patient Population
Purpose
The goal of this observational study is to test whether the ExoDx Prostate test add value in biopsy decision making to patients with prostate cancer on an active surveillance regimen.
Condition
- Prostate Cancer
Eligibility
- Eligible Ages
- Over 45 Years
- Eligible Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Male, 45+ years of age diagnosed with low-grade or favorable-intermediate prostate cancer and on an active surveillance regimen
Exclusion Criteria
- Clinical symptoms of urinary tract infection at time of enrollment. - History of invasive treatment for benign prostatic hypertrophy with in 6 months of enrollment. - Known hepatitis or HIV - History of concurrent renal/bladder tumors
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Case-Only
- Time Perspective
- Prospective
Recruiting Locations
Chesapeake Urology
Towson, Maryland 21204
Towson, Maryland 21204
Contact:
Emily Ayre
Emily Ayre
More Details
- NCT ID
- NCT05572099
- Status
- Unknown status
- Sponsor
- Exosome Diagnostics, Inc.
Detailed Description
The current trial seeks to evaluate the role of the ExoDx Prostate test in men with low and favorable intermediate prostate cancer undergoing an active surveillance regimen.